INTERNATIONAL PATENT: ORICELL THERAPEUTICS CO., LTD., 原启生物科技（上海）有限责任公司 FILES APPLICATION FOR "ANTIGEN-BINDING PROTEIN TARGETING CD38 AND USE THEREOF"

GENEVA, Feb. 8 -- ORICELL THERAPEUTICS CO., LTD. (3F, Bldg 1, No.1227 Zhangheng RoadPudong New Area, Shanghai 201203), 原启生物科技（上海）有限责任公司 (中国上海市浦东新区张衡路1227号1号楼3楼) filed a patent application (PCT/CN2025/112033) for "ANTIGEN-BINDING PROTEIN TARGETING CD38 AND USE THEREOF" on Aug 01, 2025. With publication no. WO/2026/026938, the details related to the patent application was published on Feb 05, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by...